190 related articles for article (PubMed ID: 36906605)
1. Oncogenic role and potential regulatory mechanism of fatty acid binding protein 5 based on a pan-cancer analysis.
Wang J; Zhao S; Sun J; Wang X; Guan M; Yin J; Tang B
Sci Rep; 2023 Mar; 13(1):4060. PubMed ID: 36906605
[TBL] [Abstract][Full Text] [Related]
2. The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis.
Chen S; Zhao Z; Wang X; Zhang Q; Lyu L; Tang B
Front Mol Biosci; 2022; 9():809509. PubMed ID: 35480884
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis.
Wang X; Wang J; Lyu L; Gao X; Cai Y; Tang B
Sci Rep; 2022 Jul; 12(1):11161. PubMed ID: 35778520
[TBL] [Abstract][Full Text] [Related]
4. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
5. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
[TBL] [Abstract][Full Text] [Related]
7. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.
Tang Y; Li K; Hu B; Cai Z; Li J; Tao H; Cao J
Cancer Biol Ther; 2022 Dec; 23(1):424-438. PubMed ID: 35816613
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma.
Li Y; Lee W; Zhao ZG; Liu Y; Cui H; Wang HY
World J Clin Oncol; 2024 Jan; 15(1):130-144. PubMed ID: 38292656
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
12. Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.
Shao X; Zhu J; Shi Y; Fang H; Chen J; Zhang Y; Wang J; Jian H; Lan S; Jiang F; Zhong F; Zhang Y; Cao C
Aging (Albany NY); 2022 Dec; 14(23):9632-9646. PubMed ID: 36470669
[TBL] [Abstract][Full Text] [Related]
13. Serum fatty acid-binding protein 5 is a significant factor in hepatocellular carcinoma progression independent of tissue expression level.
Ohira M; Yokoo H; Ogawa K; Fukai M; Kamiyama T; Sakamoto N; Taketomi A
Carcinogenesis; 2021 Jun; 42(6):794-803. PubMed ID: 33754641
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Fang LY; Wong TY; Chiang WF; Chen YL
J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
Tölle A; Suhail S; Jung M; Jung K; Stephan C
BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
[TBL] [Abstract][Full Text] [Related]
20. Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells.
Seo J; Jeong DW; Park JW; Lee KW; Fukuda J; Chun YS
Commun Biol; 2020 Oct; 3(1):638. PubMed ID: 33128030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
